1. Home
  2. SPB vs NVCR Comparison

SPB vs NVCR Comparison

Compare SPB & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spectrum Brands Holdings Inc.

SPB

Spectrum Brands Holdings Inc.

HOLD

Current Price

$88.92

Market Cap

2.0B

Sector

Miscellaneous

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$16.15

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPB
NVCR
Founded
1906
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
SPB
NVCR
Price
$88.92
$16.15
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$82.40
$28.08
AVG Volume (30 Days)
339.6K
1.7M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
21.79
EPS
2.16
N/A
Revenue
$3,802,100,000.00
$655,353,000.00
Revenue This Year
$2.03
$7.72
Revenue Next Year
$1.85
$6.74
P/E Ratio
$41.40
N/A
Revenue Growth
20.86
8.28
52 Week Low
$49.99
$9.82
52 Week High
$89.58
$18.92

Technical Indicators

Market Signals
Indicator
SPB
NVCR
Relative Strength Index (RSI) 63.81 48.67
Support Level $72.94 $12.49
Resistance Level N/A $18.48
Average True Range (ATR) 2.47 0.88
MACD 0.22 -0.03
Stochastic Oscillator 96.37 37.74

Price Performance

Historical Comparison
SPB
NVCR

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: